Bank of New York Mellon’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-103,404
| Closed | -$230K | – | 4492 |
|
|
2021
Q1 | $230K | Buy |
103,404
+1,976
| +2% | +$4.4K | ﹤0.01% | 4006 |
|
|
2020
Q4 | $252K | Buy |
101,428
+11,243
| +12% | +$27.9K | ﹤0.01% | 3894 |
|
|
2020
Q3 | $222K | Buy |
90,185
+350
| +0.4% | +$862 | ﹤0.01% | 3811 |
|
|
2020
Q2 | $319K | Buy |
+89,835
| New | +$319K | ﹤0.01% | 3674 |
|
|
2019
Q2 | – | Sell |
-74,758
| Closed | -$147K | – | 4293 |
|
|
2019
Q1 | $147K | Buy |
74,758
+3,295
| +5% | +$6.48K | ﹤0.01% | 3935 |
|
|
2018
Q4 | $94K | Hold |
71,463
| – | – | ﹤0.01% | 3965 |
|
|
2018
Q3 | $176K | Sell |
71,463
-1
| -0% | -$2 | ﹤0.01% | 3950 |
|
|
2018
Q2 | $240K | Buy |
71,464
+973
| +1% | +$3.27K | ﹤0.01% | 3877 |
|
|
2018
Q1 | $298K | Hold |
70,491
| – | – | ﹤0.01% | 3789 |
|
|
2017
Q4 | $233K | Sell |
70,491
-341
| -0.5% | -$1.13K | ﹤0.01% | 3873 |
|
|
2017
Q3 | $271K | Sell |
70,832
-2,527
| -3% | -$9.67K | ﹤0.01% | 3789 |
|
|
2017
Q2 | $323K | Buy |
+73,359
| New | +$323K | ﹤0.01% | 3789 |
|